Travel medicine perspectives of select travel medicine experts practicing in the Asia-Pacific region

Leder, Karin; Borwein, Sarah; Chanthavanich, Pornthep; Chatterjee, Santanu; Htun, Kaythi; Marma, Aung Swi Prue; Nakatani, Issaku; Ok, Jin Ju; Pakasi, Levina S.; Pandey, Prativa; Piyaphanee, Watcharapong; Rupali, Priscilla; Schwartz, Eli; Shinozuka, T; Phu, Phi Truong Hoang; Watanabe, Hiroshi; Visser, Jenny A.; Wilder‐Smith, Annelies; Zhang, Min; McGuinness, Sarah L.

doi:10.1093/jtm/tax012

Cited by 19 publications

(13 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar problems have been reported from countries in Asia. 28 To quantify the above-mentioned challenges of our population, we applied a 'complexity score'. This score combined different criteria, which are related to 'difficulty' and necessary level of experience in travel medicine.…”

Section: Discussionmentioning

confidence: 99%

“… 25 Furthermore, the concept of travel medicine as ‘medical care for Western tourists’ and other travellers’ health limitations, which have been recognised in Asia but similarly exist in Latin America should be taken into consideration and modernised. 28 As a first step to advance with the concept of ‘travel medicine outside the Western hemisphere’, traveller populations of less developed countries such as Chile have to be analysed and compared, in order to understand specific needs and differences. A methodological limitation of the study was that it was unicentric and performed by a single travel medicine expert, although this improves data homogeneity.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Profile and complexity of travel medicine consultations in Chile: unicentric cross-sectional study

Weitzel

2020

BMJ Open

View full text Add to dashboard Cite

ObjectiveTo analyse the spectrum, vaccination needs and pretravel advice complexity of travellers presenting at a travel medicine clinic in Santiago, Chile.DesignCross-sectional study.SettingPretravel consultations in a private healthcare centre in Chile, an ‘emerging market’ country in South America.ParticipantsTravellers (n=1341) seeking pretravel advice at the Travel Medicine Program of Clínica Alemana, Santiago, from April 2016 to March 2018.Primary and secondary outcome measuresDemographical and travel characteristics, indications for travel vaccines and malaria prophylaxis, and complexity of travel consultations.ResultsOf 1341 travellers, 51% were female; the median age was 33 years. Most frequent travel reasons were tourism (67%) and business (20%). Median travel duration and time to departure were 21 days and 28 days, respectively. Most destinations were located in America (41%), followed by Asia (36%) and Africa (26%); 96% visited less developed countries, mostly in tropical regions, with risk of arboviral infections (94%) and malaria (69%). The indicated vaccine indications comprised hepatitis A (84%), yellow fever (58%), typhoid fever (51%), rabies (29%), polio (8%), Japanese encephalitis (6%) and meningococcal meningitis (5%). More than 60% of consultations were classified as complex.ConclusionThe studied population mostly visited less developed tropical regions, resulting in a high requirement of yellow fever and other travel-related vaccinations. Most consultations were complex and required a comprehensive knowledge and training in travel medicine.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Profile and complexity of travel medicine consultations in Chile: unicentric cross-sectional study

Weitzel

2020

BMJ Open

View full text Add to dashboard Cite

show abstract

“…73 Although these are ballpark estimates derived from national averages 74 and cost data based on expert opinion, 75 they highlight the fact that out-of-pocket costs incurred by patients provide only a partial estimate of the societal-level economic burden of travel-acquired dengue illness. This exploratory study is the first to date to investigate the impact and out-of-pocket costs of travel-acquired dengue illness in ill-returned travelers, and will aid to develop evidencebased priorities in travel medicine practice 76,77 and pave the way for future economic burden studies in this population.…”

Section: Discussionmentioning

confidence: 99%

A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers

Tozan

Headley

Sewe

et al. 2019

The American Journal of Tropical Medicine and Hygiene

Self Cite

View full text Add to dashboard Cite

Although the costs of dengue illness to patients and households have been extensively studied in endemic populations, international travelers have not been the focus of costing studies. As globalization and human travel activities intensify, travelers are increasingly at risk for emerging and reemerging infectious diseases, such as dengue. This exploratory study aims to investigate the impact and out-of-pocket costs of dengue illness among travelers. We conducted a prospective study in adult travelers with laboratory-confirmed dengue and recruited patients at travel medicine clinics in eight different countries from December 2013 to December 2015. Using a structured questionnaire, we collected information on patients and their health-care utilization and out-of-pocket expenditures, as well as income and other financial losses they incurred because of dengue illness. A total of 90 patients participated in the study, most of whom traveled for tourism (74%) and visited countries in Asia (82%). Although 22% reported hospitalization and 32% receiving ambulatory care while traveling, these percentages were higher at 39% and 71%, respectively, after returning home. The out-of-pocket direct and indirect costs of dengue illness were US$421 (SD 744) and US$571 (SD 1,913) per episode, respectively, averaging to a total out-of-pocket cost of US$992 (SD 2,052) per episode. The study findings suggest that international travelers incur important direct and indirect costs because of dengue-related illness. This study is the first to date to investigate the impact and out-of-pocket costs of travel-related dengue illness from the patient's perspective and paves the way for future economic burden studies in this population.

show abstract

“…Furthermore, during the African outbreak in 2016, more unvaccinated travellers with yellow fever have been reported than in the past 50 years, showing that a substantial number of travellers are still able to circumvent the International Health Regulations. Absent or erratic control of proof of yellow fever vaccination at entry, 12 falsified vaccine certificates, flawed risk assessments in travel medicine clinics, 13 changing travel patterns and attitudes of travellers, 14,15 and inadequate information by travel medicine providers 16 have led to preventable cases of yellow fever in travellers, which contributes to the spread into new areas. Although the pre-emptive protection of endemic populations should be the main thrust, efforts should also be enhanced to contain outbreaks rapidly and to stop international spread.…”

Section: Yellow Fever Vaccination: Estimating Coveragementioning

confidence: 99%

Yellow fever vaccination: estimating coverage

Wilder‐Smith

2017

The Lancet Infectious Diseases

Self Cite

View full text Add to dashboard Cite

show abstract

Travel medicine perspectives of select travel medicine experts practicing in the Asia-Pacific region

Cited by 19 publications

References 10 publications

Profile and complexity of travel medicine consultations in Chile: unicentric cross-sectional study

Profile and complexity of travel medicine consultations in Chile: unicentric cross-sectional study

A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers

Yellow fever vaccination: estimating coverage

Contact Info

Product

Resources

About